Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and increasing fullness signals to the brain, with studies showing average weight reductions of 5-15% over 68 weeks. The number of injections you need depends on your individual response, starting dose, and treatment timeline—not a fixed number that applies to everyone. PlexusDx creates personalized injection protocols using licensed 503A compounding pharmacies to match your specific health profile.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Semaglutide Injections Support Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your gut releases after eating. When you inject semaglutide weekly, it binds to GLP-1 receptors in your brain and pancreas, reducing hunger signals and increasing feelings of fullness after smaller meals. This mechanism helps you naturally eat less without relying on restrictive willpower, making sustainable weight loss more achievable.
Clinical data shows that people using semaglutide lose significantly more weight than those on diet and exercise alone. The medication also helps stabilize blood sugar levels and may improve heart health markers in people with overweight and metabolic dysfunction. Most patients begin noticing reduced appetite within the first few weeks of starting injections.
Typical Semaglutide Injection Dosing Schedules
Semaglutide injections are given once weekly, and most treatment plans start with a low starting dose, then increase gradually every 4 weeks to minimize side effects and allow your body to adapt. A common progression might begin at 0.25 mg, then move to 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg depending on your tolerance and response. This gradual escalation helps your system adjust while maximizing the appetite-suppression benefit you experience.
The total number of injections you'll need across your weight loss journey varies widely—some people reach their goal weight in 6-12 months with 25-50 injections total, while others continue for longer depending on their starting weight and target. PlexusDx works with you to determine whether your treatment should follow a standard progression, a slower titration for sensitive systems, or a customized protocol based on your genetics and prior medication responses.
Personalizing Your Semaglutide Treatment Plan
Not everyone responds identically to the same semaglutide dose—genetic differences in GLP-1 receptor expression, appetite regulation, and metabolic pathways affect how effectively the medication works for you. PlexusDx offers the Precision Peptide Genetic Test to examine key variants including GIPR rs1800437, and FTO rs9939609, which influence your peptide sensitivity and weight-loss potential. Understanding your genetic profile helps PlexusDx design a dosing strategy that aligns with your biology rather than using a one-size-fits-all approach.
Your starting dose, escalation pace, and maintenance dose all depend on factors like your baseline metabolic rate, previous medication experiences, gastrointestinal sensitivity, and weight-loss goals. PlexusDx clinicians review these factors before recommending your personalized injection schedule, ensuring your semaglutide therapy is optimized for safety and results from day one.
Cost and Access to Semaglutide Injections at PlexusDx
PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement, no membership fees, and availability across all 50 states. Your dose may need to go up as your body adapts over weeks and months—your price won't. This flat-rate pricing means you pay one monthly fee regardless of which dose level your protocol calls for at any given time.
Semaglutide injections from PlexusDx are compounded at licensed 503A pharmacies, meet rigorous quality standards, and are HSA/FSA eligible for additional savings. If genetic insights would help optimize your treatment, the Precision Peptide Genetic Test is available for $298, giving you a data-driven edge in achieving your weight-loss goals.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
How many semaglutide injections will I need to lose weight?
The number of injections varies by individual—most people follow a 12-52 week protocol with weekly injections that gradually increase in dose. Your total count depends on your starting weight, target goal, and how quickly your body responds.
What happens if I don't respond to my starting dose?
If your appetite suppression is minimal or side effects are bothersome at your current dose, PlexusDx may adjust your next injection up or down, extend the time between dose increases, or explore whether a genetic predisposition (like specific GLP1R variants) suggests you need a different peptide altogether.
Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic?
PlexusDx sources compounded semaglutide from licensed 503A pharmacies that meet FDA manufacturing standards for quality and purity. Compounded semaglutide contains the same active pharmaceutical ingredient as brand-name versions, though compounded products are not FDA-approved.
What side effects should I expect with semaglutide injections?
Common side effects include mild nausea, constipation, and reduced appetite—the latter being the desired effect. Nausea typically decreases within 1-2 weeks as your body adapts.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
Yes—PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights including GIPR, FTO, and MC4R variants that influence your semaglutide response.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Often Are Ozempic Injections Given?
Unlocking the Brain’s Role in Weight Loss: How GLP-1 Medications Like Ozempic Affect Your Mind